Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol [3]

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3578-3579

  Scapellato, Pablo Gustavo ^a   Ormazabal, Cecilia ^a   Scapellato, José Luis ^a   Bottaro, Edgardo Gabriel ^a   Rodríguez Brieschke, María Teresa ^a   Vidal, Gabriela Inés ^a  

^a Hospital Santojanni Buenos Aires   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; EVERNIMICIN; GENTAMICIN; IMIPENEM; LINEZOLID; ORITAVANCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; VANCOMYCIN;

ADULT; BACTERIAL MENINGITIS; BACTERIUM CULTURE; BRAIN ARTERY ANEURYSM; BRAIN VENTRICLE HEMORRHAGE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CRANIOTOMY; ENTEROCOCCUS FAECIUM; FEVER; HUMAN; HYDROCEPHALUS; INTENSIVE CARE UNIT; LETTER; LUMBAR PUNCTURE; MALE; PRIORITY JOURNAL; PROVIDENCIA STUARTII; SUBARACHNOID HEMORRHAGE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; PROVIDENCIA STUARTII;

EID: 22144464470     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3578-3579.2005     Document Type: Letter

References (15)

1. Anderegg, T. R., D. J. Biedenbach, R. N. Jones, and Quality Control Working Group. 2003. Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity. J. Clin. Microbiol. 41:2795-2796.
2. Cercenado, E., S. Cercenado, J. A. Gomez, and E. Bouza. 2003. In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides. J. Antimicrob. Chemother. 52:138-139.
3. Friedman, C. A., F. C. Lovejoy, and A. L. Smith. 1979. Chloramphenicol disposition in infants and children. J. Pediatr. 95:1071-1077.
4. Kaufman, B. A. 1997. Infections of cerebrospinal fluid shunts, p. 555-577. In W. M. Scheld, R. J. Whitley, and D. T. Durak (ed.), Infections of the central nervous system, 2nd ed. Lippincott-Raven, Philadelphia, Pa.
5. Kaye, K. S., J. J. Engemann, H. S. Faimow, and E. Abrutyn. 2004. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms and clinical management. Infect. Dis. Clin. North Am. 18:467-511.
6. Lautenbach, E., M. G. Schuster, W. B. Bilker, and P. J. Brennan. 1998. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin. Infect. Dis. 27:1259-1265.
7. Lefort, A., A. Saleh-Mghir, L. Garry, C. Carbon, and B. Fantin. 2000. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 44:3017-3021.
8. McLaurin, R. L. 1973. Infected cerebrospinal fluid shunts. Surg. Neurol. 1:191-195.
9. National Nosocomial Infection Surveillance System. 1996. National Nosocomial Infection Surveillance (NISS) report: data summary from October 1986-April 1996, issued May 1996. Am. J. Infect. Control 24:380-388.
10. Pérez Mato, S., S. Robinson, and R. E. Bégué. 1999. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr. Infect. Dis. J. 18:483-484.
11. Salomon, J. H. 1978. Intraventricular chloramphenicol. Child's Brain 4:114-119.
12. Shaikh, Z. H., C. A. Peloquin, and C. D. Ericson. 2001. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand. J. Infect. Dis. 33:375-379.
13. Souli, M., C. Thauvin-Eliopoulos, and G. M. Eliopoulos. 2000. In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis. Antimicrob. Agents Chemother. 44:2733-2739.
14. Vasen, W., P. Desmery, S. Ilutovicch, and A. Di Martino. 2000. Intrathecal use of colistin. J. Clin. Microbiol. 38:3523.
15. Williamson, J. C., S. S. Glazier, J. E. Peacock Jr. 2002. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin. Neurol. Neurosurg. 104:54-56.